Carnegie Investment Counsel’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $249K | Sell |
|
|||||
|
2025
Q2 | $251K | Buy |
|
|||||
|
2025
Q1 | $221K | Sell |
|
|||||
|
2024
Q4 | $304K | Sell |
|
|||||
|
2024
Q3 | $278K | Sell |
|
|||||
|
2024
Q2 | $519K | Hold |
|
|||||
|
2024
Q1 | $537K | Sell |
|
|||||
|
2023
Q4 | $486K | Buy |
|
|||||
|
2023
Q3 | $393K | Hold |
|
|||||
|
2023
Q2 | $535K | Sell |
|
|||||
|
2023
Q1 | $490K | Sell |
|
|||||
|
2022
Q4 | $443K | Buy |
|
|||||
|
2022
Q3 | $489K | Sell |
|
|||||
|
2022
Q2 | $620K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $934K | Sell |
|
|||||
|
2021
Q3 | $952K | Buy |
|
|||||
|
2021
Q2 | $819K | Sell |
|
|||||
|
2021
Q1 | $668K | Buy |
|
|||||
|
2020
Q4 | $528K | Buy |
|
|||||
|
2020
Q3 | $406K | Hold |
|
|||||
|
2020
Q2 | $351K | Hold |
|
|||||
|
2020
Q1 | $320K | Sell |
|
|||||
|
2019
Q4 | $431K | Sell |
|
|||||
|
2019
Q3 | $423K | Sell |
|
|||||
|
2019
Q2 | $378K | Buy |
|
|||||
|
2019
Q1 | $359K | Buy |
|